News

Four projects have been selected as the inaugural awardees of the Dr. Latesha E. Elopre Health Across the Lifecourse (HEAL) Pilot Program, supporting innovative research designed to improve health outcomes across the lifespan.

Immunology Institute Director Dr.

David G. Standaert, M.D., Ph.D., chair of UAB’s Department of Neurology, joins the inaugural Advisory Council on Parkinson’s Research, Care, and Services to work toward a world without Parkinson’s disease.

UAB researchers are advancing cancer prevention and treatment through lifestyle-based survivorship care, adaptive molecular therapies and precision biomedical engineering.

Scientists identify an immune switch, NFAT, that is crucial to successful pregnancies, offering new insights on the causes of preeclampsia, implantation problems and inadequate blood supply.

UAB scientists discovered an oral drug stopped weight rebound after discontinuation or cessation of GLP‑1 treatment in preclinical studies, opening the door to a new approach for maintaining weight loss.

UAB researchers say this study shows passive antibody therapy can dramatically reduce Zika virus infection in critical tissues that could potentially lead to decreased transmission of virus through sex and from pregnant mothers to their babies.

Digestion is often thought of as a simple process confined to the stomach; but the reality is far more intricate, as one UAB researcher shares.

T-bet expression is required for persistence of memory B cells that have rapid differentiation potential to become antibody-producing plasma cells in response to a second infection.

"How do we engage with people that we are supposed to be serving?" Dr. Frances Lund, director of the Immunology Institute, said at the Aspen Ideas Health in Aspen, CO on June 25, 2025.

The understanding of how macrophages regulate their response to toxic particles via two independent pathways could uncover therapeutic opportunities to quell inflammation.

Besides their normal role, pump overexpression confers drug resistance. Knowing the structure is a step to disabling the pumps with inhibitors.

UAB is a stronghold at finding patients for studies, but healthy controls were harder.

Very-low-weight newborns need extra oxygen and can develop deadly bronchopulmonary dysplasia. Differences in gut fungi predict getting, or not getting, BPD.

The David E. Wells Memorial Symposium, a longstanding tradition in the UAB Department of Microbiology, will be held this year on May 21.

The UAB Heersink School of Medicine is proud to announce the recipients of the 2024/2025 Multi-PI Awards, each funded with $150,000 per year for two years. These awards recognize outstanding collaborative research efforts aimed at addressing critical health challenges.

Elliot Lefkowitz, Ph.D., has pioneered a unique perspective at UAB on the study of viruses: analyzing them via computational techniques, otherwise known as bioinformatics. Lefkowitz and his eight-person lab play a critical role in providing tools to scientists around the world to aid them in analyzing data related to genomic sequences.

UAB’s new Lunaphore COMET multiplex immunofluorescent platform can hyperplex up to 40 antibodies on a single pathology tissue sample.

Fran Lund, Ph.D., director of the UAB Heersink School of Medicine Immunology Institute, professor and Endowed Chair in Immunology in the Department of Microbiology, and senior scientist at the UAB O’Neal Comprehensive Cancer Center, was honored with the 2025 Distinguished Faculty Lecturer Award on Tuesday, March 18 at the UAB Alumni House.

Nine faculty members recently graduated from UAB Medicine’s LEading Advancing Developing (LEAD) spring 2025 program. The program, presented by the UAB Medicine Leadership Development Office, recognized its graduates at a ceremony on March 13, 2025.